被遗忘的巴西噬菌体疗法史
本文是一篇历史综述,通过研究巴西医学文献参考收藏,揭示巴西在20世纪噬菌体疗法中曾扮演重要角色但鲜为人知,尤其广泛使用噬菌体对抗杆菌性痢疾和葡萄球菌感染,José da Costa Cruz为巴西领先专家和先驱,填补了噬菌体疗法黄金年代的知识空白。
要点
- 巴西20世纪曾广泛使用噬菌体治疗杆菌性痢疾和葡萄球菌感染。
- José da Costa Cruz是巴西噬菌体疗法的领先专家和先驱。
- 历史经验可为当前应对耐药病原体提供参考。
核心结论
- 巴西是噬菌体疗法历史上重要但至今鲜为人知的参与者,其经验可对抗当今危险病原体。
研究设计与样本
- 历史综述,基于巴西医学文献参考收藏的研究。
主要发现
- 巴西广泛使用噬菌体对抗杆菌性痢疾和葡萄球菌感染。
- José da Costa Cruz(巴西里约热内卢Oswaldo Cruz研究所)是巴西领先专家和先驱。
- 研究揭示了有趣的优先权主张和噬菌体疗法历史的缺失片段。
临床怎么用
- 历史成功经验可为当前抗菌药物耐药危机下噬菌体疗法的应用提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The use of bacteriophages to treat bacterial infections (known as phage therapy) is considered a possible solution to the antimicrobial resistance crisis. However, phage therapy is not a new concept. The discovery of phages in the early 20th century was closely tied to clinical practice, and phage therapy quickly spread around the world. The use of phage therapy in South America in the previous century is still shrouded in mystery and has been mentioned only briefly in recent scientific literature. Research on Brazilian reference collections of medical texts showed that Brazil was an important, but so far little-known, player of phage therapy, uncovering interesting priority claims and missing pieces of phage therapy history. Of note, there is the widespread use of phages against bacillary dysentery and staphylococcal infections, with José da Costa Cruz from the Oswaldo Cruz Institute (Rio de Janeiro, Brazil) as Brazil's leading expert and pioneer. This Historical Review about historical phage use in Brazil fills the gaps in our knowledge about the so-called golden years of phage therapy, providing information about successful experiences that can be useful against dangerous pathogens in our time.
引用
- Almeida GMF, Sundberg LR. The forgotten tale of Brazilian phage therapy. Lancet Infect Dis. 2020. PMID: 32213334. doi:10.1016/S1473-3099(20)30060-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。